Oladimeji Ewumi
Freelance Health Writer at Healthline
Regulatory Medical Writer | CRO | Biopharma & Medical Devices | Bylines @healthline, @medscape, @webmd, @mdlinx, @yuancommunity, @mnt, @everydayhealth
Articles
-
4 days ago |
rheumatologyadvisor.com | Oladimeji Ewumi
Among older adults with subclinical hypothyroidism (SCH), levothyroxine (LT4) therapy can improve cardiovascular health but increase the risk for osteoporosis, fragility fractures, and all-cause mortality, according to study results published in The Journal of Clinical Endocrinology & Metabolism. Thyroid-stimulating hormone (TSH) levels naturally increase with age.
-
1 week ago |
rheumatologyadvisor.com | Oladimeji Ewumi
Oral antidiabetic drugs (OADs) are more effective than insulin therapy in lowering fracture risk among patients with type 2 diabetes (T2D), according to study results presented at the World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases held from April 10 to 13, 2025 in Rome, Italy. T2D medications may impact overall bone integrity and fracture risk.
-
1 week ago |
endocrinologyadvisor.com | Oladimeji Ewumi
Exposure to clomiphene citrate (CC) medication is associated with a greater risk for multiple gestation births and perinatal adverse events, according to study findings published in Fertility and Sterility. Since CC’s approval in 1967, its effects on obstetrical and perinatal outcomes remain unclear. In this cohort-based study, researchers aimed to evaluate the risk of multiple gestation births and perinatal adverse outcomes in pregnancies conceived with CC relative to those without CC exposure.
-
1 week ago |
thecardiologyadvisor.com | Oladimeji Ewumi
Tirzepatide dose escalation is slower in real-world settings than clinical trials among individuals without type 2 diabetes (T2D) but with multiple comorbidities, according to study results published in The Journal of Diabetes, Obesity, and Metabolism.
-
2 weeks ago |
endocrinologyadvisor.com | Oladimeji Ewumi
Among older adults with subclinical hypothyroidism (SCH), levothyroxine (LT4) therapy can improve cardiovascular health but increase the risk for osteoporosis, fragility fractures, and all-cause mortality, according to study results published in The Journal of Clinical Endocrinology & Metabolism. Thyroid-stimulating hormone (TSH) levels naturally increase with age.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 158
- Tweets
- 988
- DMs Open
- Yes
I had the privilege of sharing expert insight on the @DeltaDialog podcast about open medical data, emerging AI technologies, and closing healthcare disparity gaps with AI. Always excited to advance these conversations. 😊👌😊 https://t.co/J4aq6kcQ7X
I'm looking to speak with a neurologist for a fast turnaround story I'm working on for Well + Good. My DMs are open. Kindly help retweet or like for more reach. Thank you. #journorequest #medicaljournalist
RT @MillerGeer: Taking Tylenol when hungover can be hard on your liver as it processes the alcohol and Tylenol. Dr. Tanya Dall @ProvCalifor…